Prevalence and Factors Associated with Zero-Dose Children amongst Nomadic and Non-Nomadic Fulani in Yobe State, North-East Nigeria
Main Article Content
Keywords
Nomads and non-nomads, Fulani, Prevalence, Zero-dose, Vaccine hesitancy, Yobe
Abstract
Background: Immunization is a very cost-effective and readily available intervention capable of preventing Vaccines Preventable Diseases (VPDs). This study aimed to identify and compare the prevalence and factors associated with zero-dose immunization status among children of nomadic and non-nomadic Fulani in Yobe State, North-East Nigeria.
Methodology: A comparative cross-sectional design was used to study 348 nomadic, and 345 non-nomadic under-five children, selected using a multi-staged sampling technique. Data were collected using interviewer administered questionnaire, observation of child immunization card, and recall by the caregivers, and were analysed using IBM SPSS version 22.0 with a statistical significance set at P ≤5%.
Results: The maximum age of the nomadic caregivers was 60 and the minimum was 17 years with a mean ± SD of 28.2±7.7 years. The maximum age of the non-nomadic caregivers was 78 and the minimum was 17 years with a mean ±SD of 33.0±10.0 years. The prevalence of zero-dose children among nomadic and non-nomadic Fulani were (70.1%, 242), (61.8%, 63) respectively. The zero-dose children were significantly higher among nomads (87.2%, p<0.001) and non-nomad (54.4%, p<0.001) with no available child immunization card. The children of vaccines hesitant caregivers of nomads and non-nomads were 10 or more times more likely to be zero dose than non-hesitant caregivers (adjusted odds ratio [aOR] =477, 95% CI = [177–13031]), and (Adjusted odds ratio [aOR] =9.7, 95% CI = [2.1–44.3]) respectively.
Conclusions: The burden of zero-dose was alarmingly high among nomads compared to non-nomad Fulani despite widespread immunization outreach services in the study area. The government and relevant stakeholders should intensify Context-specific health promotion activities and outreach services targeting these underserved populations.
References
2. World Health Organization. Immunization coverage. https://www.who.int/news-room/fact-sheets/detail/immunization-coverage. Accessed 14/07/2024.
3. Aalemi AK, Shahpar K, Mubarak MY. Factors influencing vaccination coverage among children age 12–23 months in Afghanistan: Analysis of the 2015 Demographic and Health Survey. PLOS ONE. 2020;15(8):23-35.
4. Oyo-Ita AE, Hanlon P, Nwankwo O, Bosch-Capblanch X, Arikpo D, Esu E, et al. Cost-effectiveness analysis of an intervention project engaging Traditional and Religious Leaders to improve uptake of childhood immunization in Nigeria. PLOS ONE. 2021;16(9):257277.
5. Ashipala DO, Tomas N, Costa Tenete G. Barriers, and Facilitators Affecting the Uptake of COVID-19 Vaccines: A Qualitative Perspective of Frontline Nurses in Namibia. SAGE Open Nursing. 2023/01/01 2023; 9:23-41
6. Aslam F, Ali I, Babar Z, Yang Y. Building evidence for improving vaccine adoption and uptake of childhood vaccinations in low- and middle-income countries: a systematic review. Drugs & Therapy Perspectives. 2022/03/01 2022;38(3):133-145.
7. Adebimpe W.O., Adeoye O.A. Knowledge and practice of vaccination logistics management among primary health care workers in Nigeria. Human vaccines & immunotherapeutics. 2021;17(5):1490–1495
8. Mahachi K, Kessels J, Boateng K, Jean Baptiste AE, Mitula P, Ekeman E, et al. Zero- or missed-dose children in Nigeria: Contributing factors and interventions to overcome immunization service delivery challenges. Vaccine. 2022 Sep 2;40(37):5433-5444. doi: 10.1016/j.vaccine.2022.07.058.
9. World Health Organization. Immunization coverage. Key Facts 2020; Available from: https://www.who.int/news-room/fact-sheets/detail/immunization-coverage.
10. Vaccine Action Plan (GVAP), WHO, Editor. 2016, WHO: WHO Library Cataloguing-in-Publication Data.
11. Cata-Preta BO, Santos TM, Mengistu T, Hogan DR, Barros AJD, Victora CG. Zero-dose children and the immunisation cascade: Understanding immunisation pathways in low and middle-income countries. Vaccine. 2021 Jul 22;39(32):4564-4570. doi: 10.1016/j.vaccine.2021.02.072. PMC8314014.
12. National Population Commission. Official Results for 2006 House and Population Census Figures. Bureau for National Statistics Abuj; 2006. http://population.gov.ng/. Accessed 14th July, 2024.
13. Charan J, Biswas T. How to calculate sample size for different study designs in medical research? Indian J Psychol Med 2013; 35:121-6
14. Unshur A, Kikuvi G, Karama M. Determinants of Vaccination Coverage among Pastoralists in North Eastern Kenya. East African Medical Journal. 2016;93(8):333-344.
15. Wigley A, Lorin J, Hogan D, Utazi CE, Hagedorn B, Dansereau E, et al. Estimates of the number and distribution of zero-dose and under-immunised children across remote-rural, urban, and conflict-affected settings in low and middle-income countries. PLOS Glob Public Health 2022;2(10): e0001126. https://doi.org/10.1371/journal.pgph.0001126
16. Biks GA, Shiferie F, Tsegaye DA, Asefa W, Alemayehu L, Wondie T, et al. High prevalence of zero-dose children in underserved and special setting populations in Ethiopia using a generalize estimating equation and concentration index analysis BMC Public Health (2024) 24:592 https://doi.org/10.1186/s12889-024-18077-w
17. Das H, Jannat Z, Fatema K, Momo J, Ali W, Alam N. Prevalence of and factors associated with zero-dose and under-immunized children in selected areas of Bangladesh: Findings from Lot Quality Assurance Sampling Survey. Vaccine 2024;42(13):3247-3256. https://doi.org/10.1016/j.vaccine.2024.04.018.
18. Wonodi, C.; Farrenkopf, B.A. Defining the Zero Dose Child: A Comparative Analysis of Two Approaches and Their Impact on Assessing the Zero Dose Burden and Vulnerability Profiles across 82 Low- and Middle-Income Countries. Vaccines 2023;11:543.https:// doi.org/10.3390/vaccines11101543
19. Abbas K, Procter SR, van Zandvoort K, Clark A, Funk S, Mengistu T, et al. Routine childhood immunisation during the COVID-19 pandemic in Africa: a benefit–risk analysis of health benefits versus excess risk of SARS-CoV-2 infection. Lancet Glob Health 2020;8:e1264–e1272. https://doi.org/10.1016/S2214-109X(20)30308-9
20. United Nations. Sustainable development goals 2015.Available: https://www.un.org/sustainabledevelopment/
21. Hu X, Cook S, Salazar MA. Internal migration and health in China. The Lancet 2008:372:1717–1719.
22. Ogundele OA, Ogundele T, Beloved O. Vaccine hesitancy in Nigeria: Contributing factors – way forward. Niger J Gen Pract 2020; 18:1‑4.
23. Galadima AN, Zulkefli AM, Said S, Ahmad N. Factors influencing childhood immunisation uptake in Africa: a systematic review. BMC Public Health 2021; 21:1475 https://doi.org/10.1186/s12889-021-11466-5.
24. Gammino VM, Diaz MR, Pallas SW, Greenleaf AR, Kurnit MR. Health services uptake among nomadic pastoralist populations in Africa: A systematic review of the literature. PLoS Negl Trop Dis 2020 ;14(7):e0008474. https://doi.org/ 10.1371/journal.pntd.0008474
Pleas
Article Sidebar
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
This is an open-access journal and articles are distributed under the terms of the Creative Commons Attribution Non-Commercial Share-Alike License 4.0. This licence allows users to download and share, remix, tweak and build upon the article for non-commercial purposes, so long as the original authorship is acknowledged and the new creations are licensed under identical terms.